Nicotine Replacement Prescribing Trends in a Large Psychiatric Hospital, Before and After Implementation of a Hospital-Wide Smoking Ban A. Douaihy, D.

Slides:



Advertisements
Similar presentations
Mady Chalk, PhD., MSW Treatment Research Institute November, 2013.
Advertisements

We Still Haven’t Come a Long Way, Baby! Smoking Cessation Efforts in an Oregon CTP Lucy Zammarelli – Willamette Family, Inc. Barbara Tajima, University.
Click the arrows to advance forward and backward. Click the Next link below to advance to the assessment. The A B C & D’s of Suicide Assessment and Clinical.
A Clinical Flow-Chart for the “Treatment-Resistant Smoker”
Rural Medical Practitioners Health Care Delivery System
Inpatient Palliative Care: What is it and Why it’s Important Lyra Sihra MD Associate Medical Director Gentiva Hospice.
Rapid Access to Psychiatric Care Creating a “Safety Net” for High Risk Patients while decreasing Emergency Department Visits and Inpatient Admissions Oakville.
{ ADVERSE DRUG REACTIONS To ensure patient, family/caregiver and home health personnel are instructed to identify adverse reactions to medications and.
BACKGROUND US Public Health Service Clinical Practice Guideline: Treating Tobacco Use and Dependence PHS Guideline recommends four evidence- based.
Smoking and mental health Mark Allen Specialist Health Improvement Practitioner.
People with Mental Illness and Cognitive Disabilities in the Criminal Justice System Bob Fleischner Center for Public Representation.
Treating Nicotine Dependence in Patients with Addictive Disorders Eric Heiligenstein, M.D. Director of Psychiatry University Health Services University.
GAP BASICS Do you want to apply for GAP? (updated 5/14/15) AM I eligible?? You must be: Adult age 21 through 64 years old; U.S. Citizen or lawfully residing.
Drug Medi-Cal Waiver Evaluation Planning Darren Urada, Ph.D. UCLA Integrated Substance Abuse Programs January 5, 2015 The author’s views and recommendations.
TREATING SPECIAL POPULATIONS. OVERVIEW Tobacco Treatment Smoking Outcomes Co-occurring Disorders Integration Tobacco Prevention.
Dr Briju Prasad Specialty Doctor - Forensic Psychiatry
Legal risk associated with pediatric mental health telephone consultation programs. Katherine Hobbs Knutson MD, Marlynn H. Wei MD JD, Bradley D. Stein.
Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)
Frequency and type of adverse events associated with treating women with trauma in community substance abuse treatment programs T. KIlleen 1, C. Brown.
Smoking cessation outcomes of an intensive tobacco treatment program within mental health and addictions services Chizimuzo Okoli, PhD, MPH, RN Director,
P Wye, J Bowman, A Baker, J Wiggers, C Foster, M Terry, J Knight, R Clancy and V Carr THE UNIVERSITY OF NEWCASTLE AUSTRALIA.
Demonstration of a Process- Outcome Link for Smoking Cessation Melissa M. Farmer, PhD 1,2 Elizabeth M. Yano, PhD 1,2 Brian S. Mittman, PhD 1,2 Scott E.
Smoke free Interventions in Emergency Care Is it working? Is it Appropriate in EC? Vanessa Thornton Clinical Head ED Middlemore Hospital.
USERS’ INVOLVEMENT IN MENTAL HEALTH WORK. By Sylvester Katontoka
Linking Quitline Counseling & Medication Post Hospital Discharge via iPad App Post Hospital Discharge via iPad App Canadian Cancer Society Smokers’ Helpline.
Applying Science to Transform Lives TREATMENT RESEARCH INSTITUTE TRI science addiction Mady Chalk, Ph.D Treatment Research Institute CADPAAC Conference.
CCTN September 6 th, Recent Scientific Publications from the Clinical Trials Network David Liu, M.D. (CTN-0029) Harold Perl, Ph.D. (CTN-0015) Paul.
The University of Georgia Smoking Cessation Programs in Addiction Treatment Centers: An Organizational Analysis Hannah K. Knudsen, Ph.D. Lori J. Ducharme,
An approach for enabling schizophrenic in-patients to be discharge within three months Yoko NAKAYAMA, Michiko TANOUE, Junko NIMURA, Takako OHKAWA, Mayumi.
Origin and Process of Utah Guidelines Anna Fondario, MPH Utah Department of Health Violence and Injury Prevention Program.
Increasing Access to Pharmacotherapy Jonathan P. Winickoff, MD, MPH Associate Professor in Pediatrics Harvard Medical School April 26, 2013.
HIGH POINT TREATMENT CENTER High Point Treatment Center’s (H.P.T.C.) mission is to prevent and treat chemical dependency and provide therapeutic services.
SMOKING in ADOLESCENTS with PSYCHIATRIC or ADDICTIVE DISORDERS.
TOWARDS RECOVERY CLINICS Patient Care. Community Fit. An Integrated Approach to Comprehensive Treatment.
Addressing Nicotine Dependence in Drug Treatment Kimber Paschall Richter, PhD, MPH Robert M. McCool, MS University of Kansas School of Medicine, Kansas.
Smoking and Mental Health Problems in Treatment-Seeking University Students Eric Heiligenstein, M.D. University of Wisconsin-Madison Health Services Stevens.
Smoking Cessation for Recovery 2015
Tackling Obesity in NSW An LHD Perspective on integrating prevention into routine care John Wiggers Director, Population Health, Hunter New England Local.
National Conference on Tobacco or Health December 2003 Changing the System Smoking Cessation Supports for Hospital Patients and Staff Christina Krause.
Factors associated with health care providers’ practice of smoking cessation interventions in public health facilities in Kiambu County, Kenya Dr Judy.
Tobacco & SMI: Bending the Deadly Curve Gregory A. Miller, M.D. Mary Barber, M.D. Maxine Smalling, R.N. New York State Statewide Grand Rounds January 21,
Ten Years of Pharmacotherapy Trials in the CTN: An Overview.
Printed by A Follow-Up Study of Patterns of Service Use and Cost of Care for Discharged State Hospital Clients in Community-Based.
Efficacy of Combination First Line Agents for Smoking Cessation Sneha Baxi, Pharm.D. Pharmacy Practice Resident University of Illinois at Chicago.
Behavioral Health Medications and Court-Ordered Treatment Patricia R. Recupero, JD, MD.
Addressing Tobacco Use in Mental Health Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester.
Community Treatment Orders use in Assertive Outreach Dr Mohammed Al-Uzri Consultant Psychiatrist & Honorary Professor (University of Leicester)
A Perspective on Family Medicine and End-of-Life and Palliative Care Peter Selwyn, M.D., M.P.H. Professor and Chairman Department of Family & Social Medicine.
Health Professionals against Tobacco Empowering psychiatric services to deal with tobacco control I want to quit Göran Boëthius MD, PhD Tobacco Control.
AN EXAMINATION OF THE PRACTICE OF TAILORING SMOKING CESSATION PHARMACOTHERAPY IN A TOBACCO TREATMENT PROGRAM WITHIN MENTAL HEALTH AND ADDICTIONS SETTINGS.
Quick overview of quit smoking counseling for people with mental health or substance use disorders Associate Professor of.
The introduction of a routine offer of relapse prevention pharmacotherapy following successful alcohol withdrawal: A quality improvement project in a 20.
Comments to the FDA on Conditions of Safe Use To Expand Which Drug Products Can Be Considered Nonprescription Marissa Schlaifer, RPh Director of Pharmacy.
Development and Implementation of a Tobacco Cessation Toolkit
Louis E. Baxter, Sr., M.D., DFASAM, DABAM
A Client with a severe mental illness
A systematic review of the relationship between substance abuse and psychotropic medication adherence: opportunities to improve outcomes for patients with.
Tobacco Cessation Guidelines for COPD
INNOVATIVE, INTERPROFESSIONAL SIMULATION
Comments to the FDA on Conditions of Safe Use To Expand Which Drug Products Can Be Considered Nonprescription Marissa Schlaifer, RPh Director of Pharmacy.
اصول نگارش پرونده های پزشکی
Information for Network Providers
Inpatient Psychiatric Hospitalization
Abstract No. 452.
Latest trends on smoking in England from the Smoking Toolkit Study
Quality Improvement (A) (B) % Smokers Receiving Medication
Entry into RC Onset First Professional Contact
Whole-Person Care for the Seriously Mentally Ill Patient in a
Transforming the Delivery of Substance Use Disorder Treatment in States Update August 2019.
Presentation transcript:

Nicotine Replacement Prescribing Trends in a Large Psychiatric Hospital, Before and After Implementation of a Hospital-Wide Smoking Ban A. Douaihy, D. Scharf, T. Fabian, C. Fichter-DeSando & D.C. Daley Antoine Douaihy, MD Associate Professor of Psychiatry University of Pittsburgh SOM Medical Director, AMS Western Psychiatric Institute and Clinic Appalachian Tri-State Node of NIDA CTN Pre-SC Dissemination Workshop Sep 21 st, 2010

Disclosures None

Background Cigarette smoking highly prevalent among persons with psychiatric illness Cigarette smoking highly prevalent among persons with psychiatric illness >85% of seriously mentally ill persons currently smoke >85% of seriously mentally ill persons currently smoke Patients traditionally being allowed to smoke in psychiatric hospitals Patients traditionally being allowed to smoke in psychiatric hospitals New laws forcing hospitals to go smoke-free New laws forcing hospitals to go smoke-free Psychiatric inpatients may benefit from NRT to manage withdrawal interfering with recovery from mental illness Psychiatric inpatients may benefit from NRT to manage withdrawal interfering with recovery from mental illness Unknown if hospital-wide smoking bans prompt health care professionals to treat their patients nicotine withdrawal with NRT Unknown if hospital-wide smoking bans prompt health care professionals to treat their patients nicotine withdrawal with NRT

Objective To examine trends in prescribing NRT in a large psychiatric hospital (WPIC) before and after the hospital-wide smoking ban

Methodology NRT utilization data extracted from hospital pharmacy records for the 2 years before and after the ban ( additional data for one more year after) NRT utilization data extracted from hospital pharmacy records for the 2 years before and after the ban ( additional data for one more year after) Smoking ban went into effect on January 1 st, 2007 Smoking ban went into effect on January 1 st, 2007 Data represent n= 25,996 total inpatient hospital admissions Data represent n= 25,996 total inpatient hospital admissions

Primary Outcomes Change in average monthly rate of total NRT utilization from before until after the smoking ban Change in average monthly rate of total NRT utilization from before until after the smoking ban Change in average monthly rate of nicotine gum, lozenge and patch from before until after the smoking ban Change in average monthly rate of nicotine gum, lozenge and patch from before until after the smoking ban

Results

Figure 1

Figure 2

Figure 3

Conclusions Findings suggest that clinicians/physicians are more likely to identify and treat symptoms of nicotine addiction when smoking is restricted Findings suggest that clinicians/physicians are more likely to identify and treat symptoms of nicotine addiction when smoking is restricted Increased rates of treatment likely persist for months and possible years after smoking is prohibited Increased rates of treatment likely persist for months and possible years after smoking is prohibited Trainees/clinicians/practitioners should be encouraged to assess and treat nicotine withdrawal symptoms to limit interference in the treatment of psychiatric and SUDs. Trainees/clinicians/practitioners should be encouraged to assess and treat nicotine withdrawal symptoms to limit interference in the treatment of psychiatric and SUDs.